2160 S 1St Ave Suite 205, Maywood, IL 60153 708 216-9000 (Phone), 708 216-9033 (Fax)
LOYOLA UNIVERSITY MEDICAL CTR 2160 S 1St Ave, Maywood, IL 60153 708 216-9000 (Phone), 708 216-4948 (Fax)
CANSER REASERCH CENTER OF HAWAII 651 Ilalo St Suite 231, Honolulu, HI 96813 808 440-4596 (Phone), 808 587-0790 (Fax)
Certifications:
Anatomic Pathology, 1999
Awards:
Healthgrades Honor Roll
Languages:
English
Hospitals:
2160 S 1St Ave Suite 205, Maywood, IL 60153
LOYOLA UNIVERSITY MEDICAL CTR 2160 S 1St Ave, Maywood, IL 60153
CANSER REASERCH CENTER OF HAWAII 651 Ilalo St Suite 231, Honolulu, HI 96813
Loyola University Medical Center 2160 South 1St Avenue, Maywood, IL 60153
Education:
Medical School University of Rome / Tor Vergata / Faculty of Medicine And Surgery Medical School U Rome Medical School University Of Chicago Medical School Niaid Nih
Michele Carbone, Maywood IL
Work:
Loyola University Medical Center
2160 S 1St Ave, Maywood, IL 60153
University of Rome - Doctor of Philosophy University of Rome Tor Vergata, Faculty of Medicine and Surgery - Doctor of Medicine Bernard Mitchell Hospital-University of Chicago Hospitals - Residency - Anatomic Pathology Umberto I Polyclinic - Residency - Anatomic Pathology
Board certifications:
American Board of Pathology Certification in Anatomic Pathology (Pathology)
University of Hawaii Cancer Center
William and Ellen Melohn Chair In Cancer Biology
University of Hawaii Cancer Center
Director, Thoracic Oncology Program
University of Hawaii Cancer Center Dec 2008 - Dec 2014
Director
University of Hawaii John A. Burns School of Medicine Jun 2006 - Jun 2008
Chair of Pathology
University of Hawaii Cancer Center May 2006 - May 2008
Director of Thoracic Oncology at Uh Cancer Center
Education:
The University of Chicago Pritzker School of Medicine 1994 - 1996
Master In Data Intelligence E Strategie Decisionali - La Sapienza 1984 - 1988
Doctor of Medicine, Doctorates
Skills:
Leadership Clinical Research Cancer Molecular Biology Mesothelioma Research Organizational Leadership Medicine Genetics Life Sciences Research Cancer Biology Cancer Research Science Collaborative Problem Solving Cell Biology Molecular Oncology Grant Writing Public Speaking Molecular Genetics Tumor Immunology Strategy Public Health Biochemistry Collaborative Leadership Laboratory Cell Culture Grant Coordination Cross Functional Team Leadership Oncology Biotechnology Polymerase Chain Reaction Medical Education Electron Microscopy Molecular Microbiology Anatomic Pathology Presentation Skills Western Blotting
The University of Chicago Pritzker School of Medicine 1994 - 1996
Master In Data Intelligence E Strategie Decisionali - La Sapienza 1984 - 1988
Doctor of Medicine, Doctorates
Skills:
Leadership Presentation Skills Laboratory Collaborative Problem Solving Cancer Research Public Speaking Electron Microscopy Grant Coordination Medical Education Molecular Microbiology Clinical Research Life Sciences Anatomic Pathology Molecular Oncology Strategy Public Health Molecular Biology Medicine Cross Functional Team Leadership Molecular Genetics Mesothelioma Research Tumor Immunology Collaborative Leadership Cancer Research Genetics Organizational Leadership Grant Writing Cancer Biology
Languages:
English Italian Spanish
Certifications:
Board Certified In Us and Italy Medical School of Rome, La Sapienza
Joseph R. Testa - Philadelphia PA, US Michele Carbone - Honolulu HI, US Mitchell Cheung - Philadelphia PA, US Jianming Pei - Philadelphia PA, US
International Classification:
C12Q 1/68
US Classification:
506 9
Abstract:
Systems, methods, and computer readable media for diagnosing or characterizing a genetic predisposition to develop cancer are provided. Nucleic acids comprising a germline nucleic acid sequence encoding the BRCA1 associated protein 1 are sequenced or probed to determine if the nucleic acid sequence includes alterations that predispose a subject to develop cancer.
- Honolulu HI, US Michele Carbone - Honolulu HI, US
International Classification:
G01N 33/574 G01N 33/84 C07K 16/24 G01N 33/68
Abstract:
In accordance with some embodiments herein, methods of determining signatures of HMGB1 isoforms in a subject are provided. In some embodiments, antibodies that bind specifically to HMGB1 isoforms are provided. In some embodiments, immunoassay kits are provided.
- Honolulu HI, US Michele Carbone - Honolulu HI, US
Assignee:
University of Hawaii - Honolulu HI
International Classification:
G01N 33/574 C07K 16/24 G01N 33/68
Abstract:
In accordance with some embodiments herein, methods of determining signatures of HMGB1 isoforms in a subject are provided. In some embodiments, antibodies that bind specifically to HMGB1 isoforms are provided. In some embodiments, immunoassay kits are provided.
Haining Yang - Honolulu HI, US Michele Carbone - Honolulu HI, US Harvey I. Pass - New York NY, US
International Classification:
G01N 33/574
US Classification:
435 792, 436501, 435 71
Abstract:
Several embodiments provided herein relate to methods of diagnosing asbestos exposure or mesothelioma. Several embodiments also relate to methods of differentiating whether a tumor of the lung is lung cancer or mesothelioma.
Treatment And Prevention Of Cancer With Hmgb1 Antagonists
Haining Yang - Honolulu HI, US Michele Carbone - Honolulu HI, US Marco E. Bianchi - Milano, IT
International Classification:
A61K 39/395 A61K 45/06 A61K 49/00 A61K 38/17
US Classification:
424 92, 4241451, 4241431, 4241421, 514 193
Abstract:
Embodiments provided herein relate to methods and compositions for treating or preventing cancer. More particularly, several embodiments are drawn to treating or preventing malignant mesothelioma with antagonists of HMGB1.
Fox Chase scientist Joseph R. Testa said the finding could lead to new drugs. But more immediately it should enable early detection and better survival of a disease whose course is usually all too swift, said Testa, a study coleader with Michele Carbone of the University of Hawaii.
This discovery is a first step in understanding the role of the BAP1 gene and its potential utility when screening for mutations in those at high risk, said Michele Carbone, M.D., Ph.D., study co-leader and director of the University of Hawaii Cancer Center.